{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:09:20Z","timestamp":1761419360354,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.hlc.2019.12.009","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T20:29:20Z","timestamp":1577996960000},"page":"594-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Catheter and Device Management of\u00a0Inherited Cardiac Conditions"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9823-3993","authenticated-orcid":false,"given":"Richard","family":"Bennett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4793-7741","authenticated-orcid":false,"given":"Timothy","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.hlc.2019.12.009_bib1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association Strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.hlc.2019.12.009_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.amjcard.2010.06.077","article-title":"Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy","volume":"106","author":"Bos","year":"2010","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.hlc.2019.12.009_bib3","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.hlc.2019.12.009_bib4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hlc.2019.12.009_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004604","article-title":"Prognostic implications of nonsustained ventricular tachycardia in high-risk patients with hypertrophic cardiomyopathy","volume":"10","author":"Wang","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"10.1016\/j.hlc.2019.12.009_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hlc.2019.12.009_bib8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.amjcard.2017.12.044","article-title":"Impact of advanced therapies for improving survival to heart transplant in patients with hypertrophic cardiomyopathy","volume":"121","author":"Rowin","year":"2018","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.hlc.2019.12.009_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management","volume":"69","author":"Rowin","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2019.12.009_bib10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0735-1097(89)90302-1","article-title":"Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest","volume":"13","author":"Cecchi","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hlc.2019.12.009_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","article-title":"Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy","volume":"45","author":"Adabag","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hlc.2019.12.009_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.110.957290","article-title":"Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy","volume":"4","author":"Dukkipati","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.hlc.2019.12.009_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/CIRCEP.114.001568","article-title":"Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types","volume":"7","author":"Oloriz","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.hlc.2019.12.009_bib15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCEP.113.000089","article-title":"Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility","volume":"6","author":"Piers","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"10.1016\/j.hlc.2019.12.009_bib16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.hrthm.2011.03.008","article-title":"Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications","volume":"8","author":"Haqqani","year":"2011","journal-title":"Heart Rhythm"},{"issue":"21","key":"10.1016\/j.hlc.2019.12.009_bib17","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/eurheartj\/ehp306","article-title":"Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers","volume":"30","author":"Michels","year":"2009","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hlc.2019.12.009_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mri.2003.08.009","article-title":"Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy","volume":"22","author":"Teraoka","year":"2004","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.hlc.2019.12.009_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10554-008-9292-6","article-title":"Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study","volume":"24","author":"Kwon","year":"2008","journal-title":"Int J Cardiovasc Imaging"},{"issue":"14","key":"10.1016\/j.hlc.2019.12.009_bib20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.hlc.2008.03.080","article-title":"Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients","volume":"17","author":"Suk","year":"2008","journal-title":"Heart Lung Circ"},{"issue":"9","key":"10.1016\/j.hlc.2019.12.009_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacep.2018.05.007","article-title":"Outcomes of catheter ablation of ventricular tachycardia based on etiology in nonischemic heart disease: an International Ventricular Tachycardia Ablation Center Collaborative Study","volume":"4","author":"Vaseghi","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.hlc.2019.12.009_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacep.2017.12.020","article-title":"Radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy and apical aneurysm","volume":"4","author":"Igarashi","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.hlc.2019.12.009_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.15420\/AER.2016.4.3","article-title":"Arrhythmogenic cardiomyopathy: electrical and structural phenotypes","volume":"5","author":"Akdis","year":"2016","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.hlc.2018.10.013","article-title":"Arrhythmogenic cardiomyopathy in 2018-2019: ARVC\/ALVC or both?","volume":"28","author":"Bennett","year":"2019","journal-title":"Heart Lung Circ"},{"issue":"13","key":"10.1016\/j.hlc.2019.12.009_bib26","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"issue":"46","key":"10.1016\/j.hlc.2019.12.009_bib27","first-page":"3227","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"36","author":"Corrado","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hlc.2019.12.009_bib28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","article-title":"Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation","volume":"4","author":"Bai","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/CIRCEP.110.960740","article-title":"Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique","volume":"5","author":"Berruezo","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"10.1016\/j.hlc.2019.12.009_bib30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/europace\/euw062","article-title":"Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation","volume":"19","author":"Kirubakaran","year":"2017","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.hlc.2019.12.009_bib31","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.hlc.2019.12.009_bib32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0735-1097(98)00292-7","article-title":"Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia","volume":"32","author":"Ellison","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.hrthm.2014.02.016","article-title":"Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy","volume":"11","author":"Fernandez-Armenta","year":"2014","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2007.03.049","article-title":"Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"50","author":"Dalal","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.hlc.2019.12.009_bib36","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1161\/CIRCULATIONAHA.104.510503","article-title":"Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia","volume":"111","author":"Verma","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib37","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","article-title":"Catheter ablation of ventricular tachycardia in nonischemic heart disease","volume":"5","author":"Tokuda","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"10.1016\/j.hlc.2019.12.009_bib38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.hlc.2019.12.009_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.hlc.2019.12.009_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/euhj.1998.1145","article-title":"Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy","volume":"20","author":"Mestroni","year":"1999","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI62862","article-title":"Genetic mutations and mechanisms in dilated cardiomyopathy","volume":"123","author":"McNally","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"van Berlo","year":"2005","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.hlc.2019.12.009_bib44","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.hlc.2019.12.009_bib45","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hlc.2019.12.009_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.026056","article-title":"Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis","volume":"135","author":"Golwala","year":"2017","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.hlc.2019.12.009_bib47","first-page":"e210","article-title":"2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"41","key":"10.1016\/j.hlc.2019.12.009_bib48","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hlc.2019.12.009_bib49","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1540-8167.2011.02081.x","article-title":"Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention","volume":"22","author":"Frankel","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.hlc.2019.12.009_bib50","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.hrthm.2017.03.034","article-title":"Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies","volume":"14","author":"Sepehrkhouy","year":"2017","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.hlc.2019.12.009_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004328","article-title":"Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"21","key":"10.1016\/j.hlc.2019.12.009_bib52","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2010.01.041","article-title":"Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia","volume":"55","author":"Nakahara","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hlc.2019.12.009_bib53","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2004.01.029","article-title":"Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars","volume":"43","author":"Soejima","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hlc.2019.12.009_bib54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hlc.2019.12.009_bib55","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.hrthm.2016.07.001","article-title":"Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease","volume":"13","author":"Kumar","year":"2016","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.hlc.2019.12.009_bib56","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.0000083725.72693.EA","article-title":"Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia","volume":"108","author":"Hsia","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hlc.2019.12.009_bib57","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacep.2017.01.020","article-title":"Long-term outcomes of catheter ablation of electrical storm in nonischemic dilated cardiomyopathy compared with ischemic cardiomyopathy","volume":"3","author":"Muser","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.hlc.2018.10.007","article-title":"Catheter ablation of VT in non-ischaemic cardiomyopathies: endocardial, epicardial and intramural approaches","volume":"28","author":"Bhaskaran","year":"2019","journal-title":"Heart Lung Circ"},{"issue":"12","key":"10.1016\/j.hlc.2019.12.009_bib59","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.hlc.2019.12.009_bib60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1540-8167.2003.02545.x","article-title":"Implantable cardioverter defibrillator in high-risk long QT syndrome patients","volume":"14","author":"Zareba","year":"2003","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"8","key":"10.1016\/j.hlc.2019.12.009_bib61","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.hlc.2016.01.020","article-title":"Update on the diagnosis and management of familial long QT syndrome","volume":"25","author":"Waddell-Smith","year":"2016","journal-title":"Heart Lung Circ"},{"issue":"8","key":"10.1016\/j.hlc.2019.12.009_bib62","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","article-title":"Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes","volume":"108","author":"Haissaguerre","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib63","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.11622\/smedj.2013015","article-title":"Catheter ablation of ventricular fibrillation storm in a long QT syndrome genotype carrier with normal QT interval","volume":"54","author":"Yap","year":"2013","journal-title":"Singapore Med J"},{"issue":"6","key":"10.1016\/j.hlc.2019.12.009_bib64","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","article-title":"Brugada syndrome phenotype elimination by epicardial eubstrate ablation","volume":"8","author":"Brugada","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"18","key":"10.1016\/j.hlc.2019.12.009_bib66","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hlc.2019.12.009_bib67","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review","volume":"15","author":"Roston","year":"2018","journal-title":"Heart Rhythm"},{"issue":"35","key":"10.1016\/j.hlc.2019.12.009_bib68","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/eurheartj\/ehz309","article-title":"Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest","volume":"40","author":"van der Werf","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hlc.2019.12.009_bib69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.hlc.2018.10.016","article-title":"An update on the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia","volume":"28","author":"Pflaumer","year":"2019","journal-title":"Heart Lung Circ"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib70","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2013.10.027","article-title":"Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia","volume":"11","author":"Roses-Noguer","year":"2014","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib71","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCEP.111.966549","article-title":"Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with RyR2 mutation","volume":"5","author":"Kaneshiro","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.hlc.2019.12.009_bib72","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.hrcr.2019.01.012","article-title":"Successful radiofrequency catheter ablation of a premature ventricular contraction triggering ventricular fibrillation in a patient with short QT syndrome","volume":"5","author":"Morimoto","year":"2019","journal-title":"HeartRhythm Case Rep"},{"issue":"1","key":"10.1016\/j.hlc.2019.12.009_bib73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.hlc.2018.09.005","article-title":"Catheter ablation of ventricular fibrillation","volume":"28","author":"Anderson","year":"2019","journal-title":"Heart Lung Circ"},{"issue":"6","key":"10.1016\/j.hlc.2019.12.009_bib74","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jacc.2009.03.065","article-title":"Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study","volume":"54","author":"Knecht","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hlc.2019.12.009_bib75","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000027564.55739.B1","article-title":"Mapping and ablation of idiopathic ventricular fibrillation","volume":"106","author":"Haissaguerre","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hlc.2019.12.009_bib76","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacep.2018.10.014","article-title":"Incessant idiopathic ventricular fibrillation trigger originating from an unusual intramyocardial (non-purkinje) site successfully treated with catheter ablation","volume":"5","author":"Anderson","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.hlc.2019.12.009_bib77","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.hrthm.2013.12.030","article-title":"Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers","volume":"11","author":"Van Herendael","year":"2014","journal-title":"Heart Rhythm"},{"issue":"19","key":"10.1016\/j.hlc.2019.12.009_bib78","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa071968","article-title":"Sudden cardiac arrest associated with early repolarization","volume":"358","author":"Haissaguerre","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.hlc.2019.12.009_bib79","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jacc.2008.10.044","article-title":"Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy","volume":"53","author":"Haissaguerre","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.hlc.2019.12.009_bib80","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCULATIONAHA.118.039022","article-title":"Mapping and ablation of ventricular fibrillation associated with early repolarization syndrome","volume":"140","author":"Nademanee","year":"2019","journal-title":"Circulation"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950619315598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950619315598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:00:32Z","timestamp":1761415232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950619315598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1443950619315598"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2019.12.009","relation":{},"ISSN":["1443-9506"],"issn-type":[{"type":"print","value":"1443-9506"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catheter and Device Management of\u00a0Inherited Cardiac Conditions","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2019.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.","name":"copyright","label":"Copyright"}]}}